The 5HP oxytocin hair formula is unusual because it places oxytocin—a peptide hormone best known for reproductive and social-bonding biology—inside a topical hair-loss product alongside Minoxidil 5%, dutasteride and horse-placenta extract.
The live 5HP Hair Regrowth Treatment page says the product contains oxytocin for “stress-reducing and confidence-building” activity. It also describes 5HP as a hybrid formula for frontal and vertex hair loss and lists Minoxidil 5%, dutasteride and 1,000mg of horse-placenta extract as its other main components. (Hims N Hers FZ LLC)
There is emerging scientific interest in oxytocin signalling inside hair follicles. Laboratory research published in 2023 found that oxytocin influenced cultured human dermal-papilla cells and promoted hair-like sprouting in an in-vitro follicle-organoid model. A 2026 study subsequently reported that outer-root-sheath cells from human hair follicles produce oxytocin and that oxytocin signalling affected dermal-papilla activity and outer-root-sheath-cell proliferation. (PubMed)
Those studies are scientifically interesting.
They do not establish that:
- The oxytocin used in 5HP reaches scalp follicles in an active amount.
- Applying 5HP reduces psychological stress.
- 5HP lowers cortisol or anxiety.
- 5HP improves confidence through oxytocin absorption.
- Oxytocin adds clinically measurable hair growth to the finished product.
- The finished 5HP formula is more effective because it contains oxytocin.
The safest interpretation is:
Oxytocin gives 5HP an experimental follicle-signalling and stress-related formulation rationale, but the finished product’s oxytocin dose, scalp delivery, systemic exposure and clinical contribution have not been publicly demonstrated.
Direct Answer
Why does the 5HP oxytocin hair formula include oxytocin?
The manufacturer appears to position oxytocin around two separate ideas:
- General stress biology: Oxytocin participates in regulation of stress-related brain and hormonal pathways.
- Local hair-follicle biology: Laboratory studies suggest oxytocin can affect dermal-papilla and outer-root-sheath cells.
These two concepts should not be merged into one proven product claim.
A hormone may influence stress pathways when produced or delivered in a relevant systemic or central context, while also having local cellular effects in skin or hair follicles. That does not prove a topical scalp product creates both outcomes.
Does the 5HP oxytocin hair formula reduce stress when applied topically?
No human evidence was identified showing that applying 5HP to the scalp reduces:
- Perceived stress.
- Anxiety.
- Cortisol.
- Work-related pressure.
- Sleep disturbance.
- Psychological distress.
- Stress-related telogen effluvium.
The 5HP product page does not display a trial measuring any of these outcomes. (Hims N Hers FZ LLC)
Does oxytocin in the 5HP oxytocin hair formula promote hair growth?
Oxytocin has shown hair-growth-related effects in cultured cells and laboratory follicle models. Those results support further research, but they are not equivalent to clinical regrowth in people using a topical product. (PubMed)
Is oxytocin an established treatment for androgenetic alopecia?
No.
Established treatment evidence is much stronger for ingredients such as standard topical minoxidil and oral finasteride. Oxytocin remains an experimental hair-follicle research pathway.
Is the oxytocin concentration in the 5HP oxytocin hair formula public?
No oxytocin concentration, unit, amount per pump or daily exposure is displayed on the live product page. (Hims N Hers FZ LLC)
5HP Oxytocin Hair Formula: Three Claims That Must Be Kept Separate
In the 5HP oxytocin hair formula, the phrase “stress-support” can refer to three very different ideas.
| Claim Category | What Research Can Support | What Has Not Been Shown for 5HP |
| Psychological stress regulation | Oxytocin interacts with stress-related CRF and HPA-axis pathways | Topical 5HP reduces anxiety, cortisol or perceived stress |
| Stress and hair biology | Experimental stress models can alter hair cycling and follicle-cell activity | Every 5HP user’s hair loss is caused by stress |
| Local oxytocin signalling | Oxytocin can affect cultured hair-follicle cells and organoids | 5HP delivers an active oxytocin dose to follicles and improves clinical hair counts |
A responsible 5HP oxytocin hair formula article should explain all three without claiming that one proves the others.
Claim 1: Oxytocin and the Stress Response
Oxytocin is involved in complex central and peripheral biology.
A scientific review describes interaction between oxytocin and the corticotropin-releasing-factor system, noting that oxytocin may be released during or after stress and may help modulate or dampen aspects of the stress response. The authors also state that the functional significance varies and is not fully understood. (PubMed)
This supports broad scientific wording such as:
Oxytocin participates in biological systems involved in stress regulation.
It does not support the product claim:
Scalp-applied 5HP reduces the user’s stress.
Why the route matters
Research on stress regulation commonly concerns:
- Oxytocin produced inside the body.
- Oxytocin release in the brain.
- Intranasal or medically administered oxytocin.
- Neural and endocrine pathways.
- Defined doses and controlled delivery.
The 5HP oxytocin hair formula is a topical scalp formula.
The product page does not provide evidence connecting topical application to:
- Brain oxytocin concentrations.
- Blood oxytocin levels.
- Cortisol reduction.
- Anxiety scores.
- Stress-questionnaire changes.
- Confidence measurements.
“Confidence-building” is not a clinical endpoint
A user may feel more confident when satisfied with their appearance or treatment routine.
That is different from proving that topical oxytocin directly creates a confidence-building neuroendocrine effect.
The 5HP oxytocin hair formula confidence language should be treated as marketing positioning unless supported by a validated human study. (Hims N Hers FZ LLC)
Claim 2: Can Stress Affect Hair?
Stress can affect hair and scalp biology, but the relationship is not simple.
A 2025 experimental study found that intensive stress inhibited hair-follicle growth in mice through sympathetic nervous-system and cell-cycle mechanisms. The study provides mechanistic evidence, but it was not a clinical trial in people with androgenetic alopecia. (PubMed)
Earlier animal research has also shown stress-related changes in hair cycling and inflammatory signalling. These findings help explain why severe or prolonged stress may influence hair biology in some settings, but they do not establish that stress is the cause of every person’s shedding. (PubMed)
Stress-related hair loss is not one diagnosis
Hair concerns associated with stressful periods may involve:
- Telogen effluvium.
- Worsening awareness of existing shedding.
- Increased scalp scratching or grooming.
- Sleep and nutritional disruption.
- Flare-ups of inflammatory scalp conditions.
- Progression of an unrelated androgenetic pattern.
A person may also have hair loss with no major stress contribution.
Why diagnosis still matters
A “stress-support” ingredient should not delay assessment for:
- Androgenetic alopecia.
- Iron deficiency.
- Thyroid disease.
- Autoimmune alopecia.
- Scarring alopecia.
- Medication-related shedding.
- Severe nutritional restriction.
- Active scalp disease.
- Sudden or patchy loss.
Oxytocin should not be used as a shortcut diagnosis.
Claim 3: Local Oxytocin Signalling in Hair Follicles
The strongest hair-specific rationale for the 5HP oxytocin hair formula comes from cell and organoid research.
The 2023 dermal-papilla study
Researchers treated cultured human dermal-papilla cells with oxytocin.
They reported:
- Upregulation of dermal-papilla signature markers.
- Changes in growth-related gene expression.
- Increased hair-peg-like sprouting in in-vitro follicle organoids.
- Upregulation of growth-promoting factors including VEGFA. (PubMed)
What is a dermal-papilla cell?
Dermal-papilla cells sit at the base of a hair follicle and participate in signalling that influences:
- Hair-cycle activity.
- Follicle growth.
- Interactions with surrounding epithelial cells.
- Growth and regression signals.
Activity in cultured dermal-papilla cells can reveal a potential biological mechanism.
It does not prove that the 5HP oxytocin hair formula regrows scalp hair in a living person.
What is a follicle organoid?
An organoid is a laboratory model designed to reproduce selected features of a tissue.
The 2023 study used in-vitro hair-follicle organoids rather than mature human scalp follicles being treated in a clinical trial. (Nature)
An organoid result may support:
- Mechanistic plausibility.
- Further product development.
- Dose-selection research.
- Future clinical studies.
It cannot provide:
- A percentage of users who respond.
- A treatment timeline.
- A safe consumer dose.
- A direct comparison with minoxidil.
- A direct comparison with dutasteride.
- Evidence for 5HP specifically.
The 2026 Outer-Root-Sheath Study
A 2026 study examined oxytocin production and signalling in hair-follicle cells.
Researchers reported that:
- Human outer-root-sheath cells produced oxytocin.
- Oxytocin increased the hair-growth-promoting potential of dermal-papilla cells.
- Oxytocin also promoted proliferation within outer-root-sheath cells.
- The results suggested a local autocrine or paracrine role inside hair follicles. (ScienceDirect)
Why this matters
The study indicates that oxytocin is not relevant only to childbirth, lactation or brain-related social biology.
Hair follicles may have their own local oxytocin-related signalling system.
Why this still does not prove 5HP works
The study did not test:
- 5HP.
- Topical scalp application.
- The 5HP cream or solution vehicle.
- The product’s oxytocin concentration.
- Minoxidil and oxytocin together.
- Dutasteride and oxytocin together.
- Horse placenta and oxytocin together.
- Hair counts in treated patients.
- Systemic absorption.
- Long-term safety.
The research supports an experimental mechanism for the 5HP oxytocin hair formula—not a finished-product efficacy claim.
Laboratory Evidence Versus Clinical Evidence
| Evidence Level | Question Answered | Current Oxytocin Evidence |
| Cell study | Can oxytocin change dermal-papilla-cell behaviour? | Yes, under laboratory conditions |
| Organoid study | Can oxytocin influence hair-like sprouting in a model? | Yes, under the tested conditions |
| Human-follicle-cell study | Is oxytocin produced locally within hair-follicle cells? | Evidence suggests yes |
| Topical penetration study | Does scalp-applied oxytocin reach follicles at an active concentration? | Not displayed for 5HP |
| Pharmacokinetic study | How much enters blood or tissue? | Not displayed for 5HP |
| Dose-ranging trial | What topical oxytocin amount is appropriate? | Not displayed |
| Randomised human trial | Does oxytocin improve clinical hair counts? | Not identified |
| Finished 5HP trial | Does oxytocin add benefit to 5HP? | Not displayed |
What the Live 5HP Page Actually Confirms
The current canonical page is:
The older /product/hair-regrowth-treatment-5hp/ URL redirects to the current canonical destination. (Hims N Hers FZ LLC)
Verified product positioning
The page identifies the 5HP oxytocin hair formula as:
- A topical hybrid hair-regrowth treatment.
- Intended for frontal and vertex regions.
- Containing Minoxidil 5%.
- Containing dutasteride.
- Containing oxytocin.
- Containing horse-placenta extract.
- Containing a listed 1,000mg horse-placenta amount.
- Using claimed liposphere delivery technology.
- Listed under Regrowth Labs and Treatments. (Hims N Hers FZ LLC)
The product page’s oxytocin wording
The page says oxytocin has:
- Stress-reducing activity.
- Confidence-building activity.
- Pro-social activity in the older indexed description.
No 5HP oxytocin hair formula psychological or hair trial is displayed to validate those outcomes. (Hims N Hers FZ LLC)
Information the page does not confirm
- Oxytocin concentration.
- Oxytocin amount per container.
- Oxytocin amount per application.
- Oxytocin form or grade.
- Whether the oxytocin is synthetic.
- Whether potency is expressed in mass or biological units.
- Oxytocin stability through storage.
- Oxytocin follicular penetration.
- Oxytocin systemic absorption.
- Oxytocin contribution to final clinical outcomes.
- Dutasteride concentration.
- Pump volume or weight.
- Application amount.
- Frequency.
- Massage time.
- Leave-in period.
- Exact drying time.
- Missed-dose instructions.
- Full active-ingredient list.
- Complete inactive ingredients.
- Pregnancy directions.
- Finished-product clinical trial.
Critical Product-Page Consistency Problems
The live 5HP oxytocin hair formula page contains content that appears inconsistent with its own product identity.
Issue 1: The “Science Matters” section lists unrelated ingredients
The page includes statements about:
- Azelaic acid.
- Propanediol.
- Trichogen.
- A “D5α” petroleum, fragrance, sulphate and paraben statement.
Those statements resemble the D5a product description and are not clearly identified as part of the 5HP formula. (Hims N Hers FZ LLC)
Issue 2: Oxytocin is missing from “Key Active Ingredients”
The introduction says the product contains oxytocin, but the “Key Active Ingredients” section presents only:
- Minoxidil.
- Horse placenta.
- Dutasteride. (Hims N Hers FZ LLC)
This creates uncertainty about whether oxytocin is:
- A current active.
- A supporting ingredient.
- Present only in selected batches.
- Missing accidentally from the active list.
- Present at a trace or functional amount.
Issue 3: Directions are absent
The public page does not provide:
- Pump count.
- Millilitres.
- Frequency.
- Maximum amount.
- Contact time.
- Leave-in period.
- Dry-scalp wording.
No application routine should be invented.
Issue 4: Horse-placenta denominator is missing
The page states 1,000mg of horse-placenta extract but does not explain whether that amount is:
- Per container.
- Per 100mL.
- Per application.
- Raw-material equivalent.
- Actual extract weight.
- A historical formula amount.
Publication blocker
The current page should be corrected before this blog is published or used for customer counselling.
Required Product-Page Corrections
Correction 1: Publish a single verified formula
The page should show one consistent active-ingredient list.
It should clarify whether 5HP contains:
- Minoxidil 5%.
- Dutasteride at a specified concentration.
- Oxytocin at a specified concentration or amount.
- Horse-placenta extract at a specified denominator.
- Azelaic acid.
- Trichogen.
- Propanediol.
- Any additional delivery-system ingredients.
Correction 2: Remove copied D5a wording
Do not state that “D5α” contains no petroleum, fragrance, sulphate or parabens inside a 5HP page.
Replace it with batch-verified 5HP formula information.
Correction 3: Clarify oxytocin positioning
Replace broad wording such as:
“Stress-reducing and confidence-building”
with a qualified statement:
“Oxytocin has emerging laboratory relevance to hair-follicle signalling. Its contribution to the finished 5HP formula has not been established in a human clinical trial.”
Correction 4: Add complete directions
The page should display:
- Amount per application.
- Frequency.
- Treatment zones.
- Massage directions.
- Hand-washing directions.
- Drying time.
- Leave-in period.
- Missed-dose instructions.
- Maximum daily amount.
Correction 5: Add complete safety information
The page needs product-specific warnings covering:
- Minoxidil.
- Dutasteride.
- Oxytocin.
- Horse-placenta extract.
- Pregnancy transfer.
- Damaged scalp.
- Cardiovascular symptoms.
- Sexual and reproductive symptoms.
- Allergy.
- Storage.
Does Topical Oxytocin Reduce Cortisol?
No 5HP oxytocin hair formula study provides this result.
General oxytocin research has explored interactions with stress-response pathways, but the effects depend on:
- Delivery route.
- Dose.
- timing.
- Biological context.
- Study population.
- Central versus peripheral exposure.
A topical scalp formula cannot be assumed to reproduce findings from intranasal, endogenous or medically administered oxytocin.
Do not publish:
- “Lowers cortisol.”
- “Blocks the stress hormone.”
- “Stops stress shedding.”
- “Calms the nervous system.”
- “Improves emotional wellbeing.”
- “Reduces anxiety.”
- “Builds confidence biologically.”
without a direct 5HP human study.
Does Oxytocin Make Scalp Massage More Effective?
The 2023 paper notes that oxytocin can be produced in response to forms of skin stimulation, but that does not prove scalp massage creates a therapeutic oxytocin dose or that 5HP massage improves its oxytocin activity. (Nature)
Massage may help distribute a topical product when stated in the label.
It should not be claimed to:
- Release enough endogenous oxytocin to regrow hair.
- Activate the product’s oxytocin.
- Push oxytocin through the skin.
- Multiply follicle response.
- Reduce stress-related hair loss.
The live 5HP page currently does not publish a massage time.
Is Oxytocin the Main Active in 5HP?
No.
The current product positioning treats the 5HP oxytocin hair formula as a hybrid formula..
The clearest established hair-loss medicine inside the formula is Minoxidil 5%.
Dutasteride adds a DHT-targeting strategy.
Horse placenta adds a nutrient and growth-factor-related manufacturer rationale.
Oxytocin adds an experimental stress and follicle-signalling rationale. (Hims N Hers FZ LLC)
Evidence comparison
| Ingredient | Product Positioning | Independent Evidence Status |
| Minoxidil 5% | Growth engine | Established topical treatment evidence |
| Dutasteride | DHT shield | Established oral evidence; emerging topical evidence |
| Horse placenta | Nutritional and growth-factor support | Limited and indirect hair evidence |
| Oxytocin | Stress and confidence support | Emerging cell and organoid hair research |
| Liposphere technology | Deeper and longer delivery | No 5HP-specific penetration study displayed |
Minoxidil’s Role in 5HP
Minoxidil 5% is the formula’s most established topical hair-growth component.
Standard topical Minoxidil 5% is used for androgenetic alopecia and carries warnings involving:
- Chest pain.
- Rapid heartbeat.
- Faintness.
- Dizziness.
- Swelling.
- Unexplained weight gain.
- Scalp irritation.
- Unwanted facial hair. (DailyMed)
These warnings come from standard minoxidil products, not from an independently tested 5HP label.
They should be treated as minimum safety context because 5HP contains additional actives and has no displayed finished-product safety trial.
What cannot be inferred
The product page does not show whether 5HP’s:
- Minoxidil is w/v or w/w.
- Vehicle matches standard minoxidil.
- Daily minoxidil exposure matches a standard product.
- Absorption is increased by liposphere technology.
- Adverse-event rate is the same as basic Minoxidil 5%.
Dutasteride’s Role in 5HP
Dutasteride inhibits 5-alpha-reductase enzymes involved in converting testosterone to DHT.
The 5HP page does not state the dutasteride concentration. (Hims N Hers FZ LLC)
A 2025 phase II trial studied separate topical dutasteride solutions at 0.01%, 0.02% and 0.05% w/v in men with androgenetic alopecia. That research supports the possibility of topical dutasteride treatment, but its results cannot be assigned to 5HP without knowing the product’s concentration, vehicle and application amount. (PubMed)
Pregnancy-transfer context
Official oral dutasteride labelling warns that dutasteride can be absorbed through skin and that pregnant or potentially pregnant people should not handle leaking capsules because of potential risk to a male fetus. This is oral-capsule class safety information—not a 5HP topical exposure study—but it supports strict wet-product transfer precautions for an undisclosed topical dutasteride formula. (DailyMed)
Horse Placenta’s Role in 5HP
The page lists horse-placenta extract at 1,000mg and describes it as a source of:
- Amino acids.
- Peptides.
- Vitamins.
- Growth factors.
- Nutritional support. (Hims N Hers FZ LLC)
The public page does not provide:
- Source species documentation beyond “horse.”
- Amount denominator.
- Extraction method.
- Growth-factor assay.
- Follicle-penetration data.
- Allergen declaration.
- Certificate of analysis.
- Finished-product trial.
The horse-placenta component should not be used to support the oxytocin claim unless the manufacturer proves that the extract itself contains a measured oxytocin amount.
Could Horse Placenta Be the Source of Oxytocin?
The public page does not explain whether 5HP’s oxytocin is:
- Added as a separate synthetic ingredient.
- Naturally associated with the placenta extract.
- A purified peptide.
- A labelled biological extract component.
- Present at a standardised potency.
This distinction matters.
If oxytocin is separately added, the label should state:
- Ingredient identity.
- Concentration.
- Grade.
- Stability.
- Amount per application.
If the claim is based only on natural presence within horse placenta, the manufacturer should provide:
- Analytical verification.
- Batch consistency.
- Amount.
- Activity after processing.
- Stability after storage.
Do not assume the source.
Is Oxytocin Stable in a Topical Hair Formula?
The public 5HP oxytocin hair formula page provides no stability data for oxytocin.
Questions requiring answers include:
- Does the formula protect the peptide from degradation?
- What pH is used?
- Is refrigeration required?
- Is the bottle protected from light?
- How long is the product stable after opening?
- Does oxytocin remain active throughout the expiry period?
- Does liposphere technology encapsulate oxytocin specifically?
- Has batch potency been measured?
Without stability testing, the word “contains” does not establish active exposure at the end of shelf life.
Does Liposphere Technology Deliver Oxytocin to Hair Follicles?
The manufacturer says liposphere technology penetrates deeper and increases exposure to actives. (Hims N Hers FZ LLC)
The page does not provide:
- Particle size.
- Encapsulation efficiency.
- Which actives are encapsulated.
- Oxytocin-loading data.
- Release profile.
- Human scalp penetration.
- Blood-level measurements.
- Comparison with a non-liposphere vehicle.
The delivery claim must therefore be presented as manufacturer positioning.
Its detailed discussion belongs to the separately scheduled 5HP delivery-technology article.
Can 5HP Treat Stress-Related Telogen Effluvium?
No 5HP oxytocin hair formula evidence establishes this indication.
Telogen effluvium may occur after:
- Illness.
- Surgery.
- Major psychological stress.
- Childbirth.
- Rapid weight loss.
- Nutritional deficiency.
- Medication changes.
- Endocrine disturbance.
Management depends on identifying and addressing the trigger.
A hybrid androgenetic-alopecia formula containing minoxidil and dutasteride should not automatically be recommended for every case of diffuse stress-related shedding.
The product page positions 5HP for frontal and vertex areas, which is more consistent with patterned hair-loss coverage than with a diagnosis of general stress shedding. (Hims N Hers FZ LLC)
Can 5HP Improve Confidence?
A person may experience greater confidence after improvement in appearance, better styling or feeling proactive about treatment.
That psychological outcome is different from proving a direct oxytocin effect.
The page does not display:
- A confidence questionnaire.
- Quality-of-life scores.
- Placebo comparison.
- Oxytocin blood levels.
- Blinded assessment.
- Clinical psychology outcomes.
Safer wording is:
The manufacturer associates oxytocin with confidence-related biology, while any actual confidence improvement from using 5HP remains an individual, unverified outcome.
Oxytocin Safety Context
Medical oxytocin is a biologically active hormone.
Official injectable oxytocin is used because it stimulates uterine smooth-muscle contractions. That medical route and dose are entirely different from 5HP topical use. The injection label cannot be used to predict topical 5HP exposure, but it demonstrates why the product needs pregnancy-specific safety documentation rather than being treated as an ordinary cosmetic ingredient. (DailyMed)
Do not infer injection risks directly
It would be inaccurate to claim that scalp-applied 5HP causes:
- Labour.
- Uterine contractions.
- Water intoxication.
- Cardiovascular effects associated with medical infusion.
No 5HP exposure data support those conclusions.
Evidence-safe precaution
Because:
- The oxytocin amount is unknown.
- Systemic absorption is unknown.
- Dutasteride is present.
- Pregnancy directions are absent.
pregnant or potentially pregnant individuals should avoid applying or contacting wet 5HP until qualified medical and manufacturer guidance is available.
Household Transfer Precautions
Until the physical label provides complete directions:
- Apply the product yourself where practical.
- Keep it on the intended scalp zones.
- Wash the hands immediately.
- Prevent forehead and facial runoff.
- Allow the application to dry.
- Avoid wet-scalp contact with another person.
- Avoid transfer through pillows, towels, caps and helmets.
- Clean spills promptly.
- Keep the bottle away from children.
- Replace a damaged or leaking container.
The strictest concern comes from the undisclosed topical dutasteride component.
Cardiovascular and Hormonal Safety
Minoxidil-related symptoms
Stop and seek medical advice for:
- Chest pain.
- Rapid heartbeat.
- Faintness.
- Dizziness.
- Sudden swelling.
- Unexplained weight gain.
- Severe scalp irritation. (DailyMed)
Dutasteride-related concerns
Discuss new or persistent:
- Reduced libido.
- Erectile difficulty.
- Ejaculation changes.
- Fertility concerns.
- Testicular discomfort.
- Breast tenderness.
- Breast enlargement.
- Breast lumps or nipple discharge.
- Relevant prostate or PSA assessment.
No 5HP-specific adverse-event rates are publicly displayed.
Oxytocin-related uncertainty
Report any unusual systemic symptom occurring repeatedly after application.
Do not automatically assign it to oxytocin, minoxidil or dutasteride without assessment.
Do Not Combine 5HP Independently With Other Treatments
5HP with 7HP
7HP Hair Regrowth Treatment is another hybrid Regrowth Labs formula.
Do not layer, alternate or rotate 5HP and 7HP without medical direction.
5HP with D5a
D5a Dutasteride 0.5% treatment contains a disclosed high topical dutasteride concentration.
5HP already lists dutasteride, so combining them may increase total exposure.
5HP with M7α
M7α 7% Minoxidil treatment is a minoxidil-focused alternative.
5HP already contains Minoxidil 5%.
Do not add M7α merely to increase the minoxidil percentage.
Other combinations to avoid without review
- Generic Minoxidil 5%.
- Oral minoxidil.
- Oral dutasteride.
- Finasteride tablets.
- FIN25.
- FR12.
- FR16.
- Microneedling protocols.
A clinician needs the complete 5HP dose before total exposure can be assessed.
Product Alternatives by Formula Priority
A buyer should choose according to the clinically relevant treatment goal—not according to the novelty of oxytocin.
A buyer focused on a hybrid formula
Review 5HP Hair Regrowth Treatment after complete label verification.
A buyer comparing a related hybrid strength
Review 7HP Hair Regrowth Treatment.
A buyer focused mainly on topical DHT blocking
Review D5a Dutasteride 0.5% treatment.
A buyer focused mainly on a minoxidil solution
Review M7α 7% Minoxidil treatment.
These are navigation options, not personalised recommendations or an efficacy ranking.
Readers may browse the wider Regrowth Labs hair-care range and other hair-loss treatments available in the UAE.
Product-Label Verification Checklist
Product identity
- Product name states 5HP.
- Current canonical product and physical package match.
- Bottle and carton identify a topical hair treatment.
- Frontal and vertex positioning is confirmed.
- Manufacturer is identified.
- Batch number is visible.
- Expiry date is visible.
Oxytocin
- Oxytocin is listed on the physical ingredient panel.
- Oxytocin concentration is stated.
- Oxytocin amount per application is stated.
- Oxytocin source is identified.
- Pharmaceutical, cosmetic or research grade is clarified.
- Biological units or mass units are clearly stated.
- Stability data are available.
- Storage requirements are stated.
- Pregnancy warning is present.
- Systemic-exposure information is available.
Minoxidil
- Minoxidil USP 5% is confirmed.
- Percentage basis is stated.
- Amount per application is stated.
- Maximum daily exposure is stated.
- Cardiovascular warnings are included.
- Dry-scalp wording is checked.
- Leave-in instructions are checked.
Dutasteride
- Dutasteride is confirmed.
- Concentration is stated.
- Amount per application is stated.
- Pregnancy-transfer warning is present.
- Sexual and reproductive warnings are present.
- PSA and medical-disclosure guidance is checked.
- Combination-treatment warning is present.
Horse placenta
- 1,000mg amount is confirmed.
- Denominator is stated.
- Extract versus raw-equivalent weight is clarified.
- Horse species source is documented.
- Extraction process is described.
- Allergy declaration is included.
- Batch testing is available.
- Growth-factor claims are analytically verified.
- Halal status is verified where claimed.
Formula consistency
- Azelaic-acid presence or absence is clarified.
- Trichogen presence or absence is clarified.
- Propanediol presence or absence is clarified.
- Liposphere ingredients are identified.
- Nanosome claim is verified.
- D5a wording has been removed.
- Complete INCI list is available.
- Alcohol content is stated.
- Propylene-glycol content is stated.
- Fragrance is declared.
- Preservatives are declared.
- Colourants are declared.
Directions
- Quantity per application is stated.
- Pump count is stated.
- Frequency is stated.
- Massage time is stated.
- Hand washing is stated.
- Drying time is stated.
- Leave-in time is stated.
- Missed-dose instructions are stated.
- Early-washing instructions are stated.
- Maximum daily amount is stated.
Storage and safety
- Storage temperature is stated.
- Light protection is stated.
- Heat protection is stated.
- Freezing guidance is stated.
- Expiry after opening is stated.
- Damaged-scalp warning is present.
- Microneedling warning is present.
- Eye-contact instructions are present.
- Accidental-ingestion instructions are present.
- Child-safety directions are present.
For missing oxytocin, dutasteride, pump or stability information, contact Hims & Hers UAE before use.
Evidence Hierarchy
Level 1 — Verified 5HP product-page facts
The live page confirms:
- Minoxidil 5%.
- Dutasteride.
- Oxytocin.
- Horse placenta 1,000mg.
- Frontal and vertex positioning.
- Claimed liposphere delivery. (Hims N Hers FZ LLC)
Level 2 — Established minoxidil evidence
Minoxidil 5% has established topical hair-loss evidence and recognised label warnings. (DailyMed)
Level 3 — Dutasteride evidence
Oral dutasteride has clinical hair-loss evidence, and emerging topical trials have tested defined low concentrations. (PubMed)
Level 4 — Oxytocin cell and organoid evidence
Oxytocin has influenced dermal-papilla-cell markers and hair-like sprouting in laboratory models. (PubMed)
Level 5 — Local follicle oxytocin evidence
Outer-root-sheath cells have been shown to produce oxytocin and participate in local follicle signalling in laboratory research. (ScienceDirect)
Level 6 — Stress and hair experimental evidence
Animal and mechanistic studies support a relationship between intensive stress and disrupted follicle growth. (PubMed)
Level 7 — Missing 5HP clinical bridge
The public evidence does not show:
- 5HP oxytocin concentration.
- Topical oxytocin penetration.
- Oxytocin pharmacokinetics.
- Reduced perceived stress.
- Reduced cortisol.
- Confidence improvement.
- Oxytocin-specific hair-count improvement.
- 5HP randomised trial.
- Added benefit compared with the same formula without oxytocin.
- Long-term 5HP safety.
Manufacturer Claims Versus Independent Evidence
| Topic | Manufacturer Positioning | Evidence-Safe Interpretation |
| Oxytocin reduces stress | Broad stress-support claim | Oxytocin participates in stress biology, but topical 5HP has not been shown to reduce psychological stress |
| Oxytocin builds confidence | Product marketing language | No validated 5HP confidence outcome is displayed |
| Oxytocin promotes hair growth | Implied formula rationale | Cell and organoid studies are promising but not clinical proof |
| Stress causes hair loss | Used to support the formula | Stress may affect hair, but not every case is stress driven |
| Minoxidil 5% | Growth engine | Established topical evidence; 5HP dose and vehicle still require verification |
| Dutasteride | DHT shield | Evidence exists for dutasteride, but 5HP concentration is missing |
| Horse placenta 1,000mg | Nutritional support | Amount denominator, processing and follicle delivery are unclear |
| Liposphere technology | Deeper active exposure | No 5HP-specific penetration or comparative study is displayed |
| Frontal and vertex treatment | Product positioning | Exact diagnosis and individual suitability still require assessment |
| All-in-one hybrid | Convenience and multi-pathway positioning | More ingredients do not automatically mean greater efficacy or safety |
Who Might Discuss 5HP With a Clinician?
The 5HP oxytocin hair formula may deserve professional discussion for an adult who:
- Has confirmed androgenetic alopecia.
- Has frontal or vertex thinning.
- Has reviewed Minoxidil 5%.
- Has reviewed topical dutasteride.
- Understands that oxytocin evidence is experimental.
- Understands that stress support is not a proven psychological outcome.
- Can obtain the complete physical label.
- Can avoid duplicate minoxidil and dutasteride exposure.
- Has an intact scalp.
- Can follow pregnancy-transfer precautions.
- Understands that the 5HP application schedule is missing online.
- Has realistic expectations about horse-placenta and delivery claims.
- Will report cardiovascular, sexual or allergic symptoms.
Who Should Not Self-Start 5HP?
Professional assessment is especially important for:
- People without a confirmed diagnosis.
- People with sudden or patchy hair loss.
- People assuming stress is the only cause.
- People with heart disease.
- People with low blood pressure.
- People using blood-pressure medicines.
- People using oral minoxidil.
- People using another topical minoxidil.
- People using oral or topical dutasteride.
- People using finasteride.
- Men with fertility concerns.
- People undergoing PSA assessment.
- Pregnant or breastfeeding individuals.
- People who may expose a pregnant household member.
- Children and adolescents.
- People with animal-protein allergy.
- People with scalp inflammation or infection.
- People planning microneedling.
- People with a recent hair transplant.
- People unable to verify the exact ingredients and directions.
Buyer Decision Checklist
Before purchasing the 5HP oxytocin hair formula, confirm:
- My hair-loss diagnosis is established.
- I understand that 5HP is a hybrid medicinal formula.
- I know Minoxidil 5% is present.
- I know the dutasteride concentration.
- I know the oxytocin concentration.
- I know what “1,000mg horse placenta” refers to.
- I have the complete ingredient list.
- I have verified whether azelaic acid and Trichogen are truly present.
- I understand that oxytocin laboratory evidence is not a human 5HP trial.
- I understand that topical 5HP has not been proven to reduce stress.
- I understand that it is not a treatment for anxiety.
- I know the verified application amount.
- I know the verified frequency.
- I know the drying and leave-in instructions.
- I am not duplicating minoxidil.
- I am not duplicating dutasteride.
- Pregnancy-transfer precautions can be followed.
- I know the symptoms requiring medical advice.
- I can obtain product clarification before starting.
Buyer Decision Flowchart
Considering 5HP because of oxytocin?
│
▼
Has the cause of hair loss been diagnosed?
┌────┴────┐
No Yes
│ │
Seek diagnosis Are minoxidil and
dutasteride appropriate?
┌────┴────┐
No Yes
│ │
Choose another Is the exact oxytocin
strategy and dutasteride dose known?
┌────┴────┐
No Yes
│ │
Do not start Are you expecting
until verified stress or anxiety
treatment?
┌────┴────┐
Yes No
│ │
Reset expectations Can all label,
and seek appropriate safety and transfer
stress support requirements be met?
┌────┴────┐
No Yes
│ │
Reassess product Discuss 5HP
with clinician
Final Verdict: Why Does 5HP Include Oxytocin?
The oxytocin ingredient gives the 5HP oxytocin hair formula an unusual scientific narrative.
That narrative is based on two areas of research:
- Oxytocin’s involvement in stress-regulation biology.
- Emerging evidence that oxytocin participates in local hair-follicle signalling.
Recent laboratory research has shown that oxytocin can affect dermal-papilla cells, hair-follicle organoids and outer-root-sheath cells. These findings make oxytocin a legitimate experimental hair-research target. (PubMed)
They do not prove that 5HP:
- Reduces stress.
- Improves confidence.
- Lowers cortisol.
- Stops stress-related shedding.
- Delivers oxytocin to follicles.
- Produces better hair results because oxytocin is present.
5HP’s public page also leaves major practical questions unanswered, including:
- Oxytocin concentration.
- Dutasteride concentration.
- Application amount.
- Frequency.
- Leave-in time.
- Full ingredients.
- Stability.
- Product-specific safety.
The most accurate conclusion for the 5HP oxytocin hair formula is:
Oxytocin is included in 5HP as an emerging follicle-signalling and stress-related concept, but its actual contribution to the finished product remains unproven until dose, delivery and clinical-outcome data are published.
Review the live 5HP Hair Regrowth Treatment page and physical package before use.
Relevant formula alternatives include:
Readers may also browse:
- The wider Regrowth Labs hair-care range
- Other men’s hair-care products available in the UAE
- The complete collection of hair-loss treatments available in the UAE
- Ordering and delivery information in the Hims & Hers UAE FAQs
For the oxytocin concentration, dutasteride percentage, horse-placenta denominator, complete directions, damaged packaging or unexpected reaction, contact Hims & Hers UAE before using the product.
Frequently Asked Questions
Why does 5HP contain oxytocin?
The manufacturer associates oxytocin with stress-related and confidence-related biology. Laboratory research also suggests oxytocin can influence hair-follicle cells, but its contribution to the finished 5HP formula is not clinically established. (Hims N Hers FZ LLC)
Is oxytocin a hair-growth hormone?
Oxytocin is a peptide hormone with many biological roles. Recent laboratory studies suggest it may participate in hair-follicle signalling, but it is not an established clinical hair-loss treatment.
Does applying 5HP reduce psychological stress?
No human 5HP study is displayed showing reduced anxiety, cortisol or perceived stress.
Does 5HP improve confidence?
The product page uses confidence-building language, but no validated confidence or quality-of-life study is displayed. (Hims N Hers FZ LLC)
Can stress cause hair loss?
Severe or prolonged stress may influence hair cycling in some circumstances, but it is not the cause of every case of thinning or shedding. (PubMed)
Does oxytocin help dermal-papilla cells?
A 2023 laboratory study reported changes in dermal-papilla-cell markers and increased hair-like sprouting in an in-vitro organoid model. (PubMed)
Do hair follicles produce oxytocin?
A 2026 laboratory study reported oxytocin production by outer-root-sheath cells and local effects on hair-follicle-cell activity. (PubMed)
Do those studies prove that 5HP regrows hair?
No. The studies did not test the finished 5HP product, topical scalp dosing or clinical hair counts.
Is there a human clinical trial of topical oxytocin for androgenetic alopecia?
No directly applicable human topical-oxytocin hair-loss trial was identified in this audit.
What is the oxytocin concentration in 5HP?
The live product page does not state the oxytocin concentration or amount per application. (Hims N Hers FZ LLC)
Is the oxytocin synthetic or placenta-derived?
The public product page does not identify its source.
Does 5HP contain Minoxidil 5%?
Yes. The current page lists Minoxidil 5% as a main active. (Hims N Hers FZ LLC)
Does 5HP contain dutasteride?
Yes, but the current page does not state the dutasteride percentage. (Hims N Hers FZ LLC)
Does 5HP contain horse placenta?
Yes. The page lists 1,000mg of horse-placenta extract, but it does not state whether that figure is per bottle, serving or raw-material equivalent. (Hims N Hers FZ LLC)
Does the 5HP product page provide directions?
The current public page does not display a verified pump count, application frequency or leave-in period.
Can 5HP be used every day?
Do not assume daily use. Follow the physical product label or qualified professional instructions.
Can 5HP be used for telogen effluvium?
It should not be self-selected for stress-related shedding without a diagnosis. The product is positioned for frontal and vertex hair loss.
Can 5HP treat anxiety?
No. It is a topical hair product, not an approved anxiety treatment.
Can 5HP be combined with 7HP?
Do not layer or alternate hybrid minoxidil-dutasteride products without medical direction.
Can 5HP be used with D5a?
Do not combine them independently because both list dutasteride.
Can 5HP be used with M7α?
Do not combine them independently because both list minoxidil.
Can pregnant women touch 5HP?
Pregnant or potentially pregnant people should avoid contact with wet 5HP until product-specific guidance is available, particularly because it contains dutasteride.
Can 5HP cause minoxidil-related symptoms?
Standard Minoxidil 5% warnings include chest pain, rapid heartbeat, dizziness, faintness, swelling and unexplained weight gain. (DailyMed)
Can 5HP cause sexual side effects?
Systemic exposure to dutasteride cannot be assessed because the product concentration and pharmacokinetics are not public. Report new sexual or reproductive symptoms to a clinician.
Can 5HP be used after microneedling?
Do not apply it over freshly microneedled, bleeding or damaged scalp without a clinician-designed protocol.
What should be corrected on the 5HP webpage?
The page needs one consistent formula, oxytocin and dutasteride concentrations, full directions, safety warnings and removal of copied D5a wording.